The global mycoplasma testing markets growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
The global Mycoplasma Testing Market
size is projected to reach USD 1,095 million by 2025
from USD 689 million in 2020, at a CAGR of 9.7%.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136509856
Market Segmentation: -
The mycoplasma testing market is segmented into
assays, kits, & reagents; instruments; and services based on product &
service. In 2019, the assays, kits, & reagents segment accounted for this
markets largest share. The frequent purchase of these consumables compared to
instruments and the increasing use of kit-based techniques for mycoplasma
testing are the essential factors driving this market segments growth.
Based on application, the mycoplasma testing market
is segmented into cell line testing, virus testing, and end-of-production cell
testing. In 2019, the cell line testing segment accounted for the largest share
of this market. Factors such as the rapid growth in the biopharmaceutical
industry and the increasing demand for monoclonal antibodies drive this market
segments growth.
Regional Analysis:-
The global mycoplasma testing market is segmented
into North America, Europe, the Asia Pacific, and the Rest of the World. In
2019, North America accounted for the largest share of the global mycoplasma
testing market. The large share can be attributed primarily to the growth in
biotechnology and pharmaceutical industries, the high adoption rate of novel
technologies, and the large number of life science research studies conducted
in this region.
Recent Developments
- In July 2020, Roche
Diagnostics launched Cobas 6800, a fully automated system in India.
- In July 2020, Creative
Bioarray launched a full range of cell-based services
- In January 2020,
Charles River Laboratories (US) acquired HemaCare Corporation (US)
Speak To Analyst :- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=136509856
Top Key Players:-
The major players operating in this market are
Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International,
Inc. (US), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche
Diagnostics (Switzerland), American Type Culture Collection (US) and Bionique Testing Laboratories, Inc. (US),
No comments:
Post a Comment